{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:03:47Z","timestamp":1719792227319},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.gofs.2017.12.011","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T20:11:34Z","timestamp":1517515894000},"page":"124-129","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quels sont l\u2019objectif r\u00e9el et la port\u00e9e du d\u00e9pistage des aneuplo\u00efdies\u00a0?"],"prefix":"10.1016","volume":"46","author":[{"given":"T.","family":"Quibel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2017.12.011_bib0210","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum \u03b1-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0215","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"First Trimester maternal serum biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21\u00a0and 18","volume":"349","author":"Wapner","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0220","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajog.2006.02.046","article-title":"Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population","volume":"195","author":"Rozenberg","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2017.12.011_bib0230","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/clinchem\/46.12.1903","article-title":"Fetal DNA in maternal plasma: biology and diagnostic applications","volume":"46","author":"Lo","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.gofs.2017.12.011_bib0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.347","article-title":"Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data","volume":"22","author":"Bianchi","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.gofs.2017.12.011_bib0240","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gofs.2017.12.011_bib0245","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gofs.2017.12.011_bib0250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0255","first-page":"56","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"10","author":"Wald","year":"2003","journal-title":"J Med Screen"},{"key":"10.1016\/j.gofs.2017.12.011_bib0260","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0265","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/AOG.0000000000001040","article-title":"Detection rates for aneuploidy by first trimester and sequential screening","volume":"126","author":"Baer","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-200701000-00054","article-title":"Practice Bulletin, No.77: screening for fetal chromosomal abnormalities","volume":"109","author":"American College of Obstetricians and, Gynecologists","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0275","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajog.2012.01.029","article-title":"Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21\u00a0and trisomy 18","volume":"206","author":"Ashoor","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0280","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajog.2012.05.021","article-title":"Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21\u00a0and trisomy 18","volume":"207","author":"Norton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0285","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajog.2012.01.030","article-title":"Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21\u00a0and trisomy 18","volume":"206","author":"Sparks","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0290","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajog.2014.03.042","article-title":"Noninvasive prenatal screening for fetal trisomies 21, 18, 13\u00a0and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA","volume":"211","author":"Porreco","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0295","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Source to accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0300","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for non-invasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0305","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1311037","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","volume":"370","author":"Bianchi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0310","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2014.08.006","article-title":"Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing","volume":"211","author":"Dar","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0315","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/uog.14792","article-title":"Noninvasive prenatal testing for trisomy 21, 18\u00a0and 13\u00a0\u2013\u00a0clinical experience from 146,958\u00a0pregnancies","volume":"45","author":"Zhang","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0320","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0325","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/01.AOG.0000471171.86798.ac","article-title":"Committee opinion 640: cell-free, DNA, screening for fetal, aneuploidy","volume":"126","author":"American College of Obstetricians and, Gynecologists","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphismbased noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0335","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/gim.2014.3","article-title":"Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results","volume":"16","author":"Grati","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0340","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.15006","article-title":"Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study","author":"Chan","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2017.12.011_bib0345","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based non-invasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0350","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0355","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pd.4541","article-title":"Circulating cell free DNA testing: are some test failures informative?","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.gofs.2017.12.011_bib0360","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000337373","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11\u201313\u00a0weeks\u2019 gestation: effect of maternal and fetal factors","volume":"31","author":"Ashoor","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.gofs.2017.12.011_bib0365","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/gim.2011.73","article-title":"DNA sequencing of maternal plasma reliably identifies trisomy 18\u00a0and trisomy 13\u00a0as well as Down syndrome: an international collaborative study","volume":"14","author":"Palomaki","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0370","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ajog.2015.12.018","article-title":"Cell-free DNA vs. sequential screening for the detection of fetal chromosomal abnormalities","volume":"214","author":"Norton","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0375","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajog.2015.12.025","article-title":"Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center","volume":"214","author":"Shani","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.14636","article-title":"Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review andmeta-analysis","volume":"45","author":"Akolekar","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0385","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0390","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/14767058.2013.825601","article-title":"How does altering the resolution of chromosomal microarray analysis in the prenatal setting affect the rates of pathological and uncertain findings?","volume":"27","author":"Hillman SC1","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.gofs.2017.12.011_bib0395","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/pd.4685","article-title":"Routine use of array comparative genomic hybridization (aCGH) as standard approach for prenatal diagnosis of chromosomal abnormalities. Clinical experience of 1763\u00a0prenatal cases","volume":"35","author":"Papoulidis","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.gofs.2017.12.011_bib0400","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jmg.2008.065482","article-title":"High-resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings","volume":"46","author":"Tyreman","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.gofs.2017.12.011_bib0405","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1097\/AOG.0000000000001406","article-title":"Practice Bulletin No. 163: screening for fetal aneuploidy","volume":"127","author":"Committee on Practice Bulletins\u00a0\u2013\u00a0Obstetrics","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2017.12.011_bib0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajog.2016.02.030","article-title":"Clinical validation of a non invasive prenatal test for genomewide detection of fetal copy number variants","volume":"215","author":"Lefkowitz","year":"2016","journal-title":"Am J Obstet Gynecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718917303823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718917303823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T22:25:45Z","timestamp":1719786345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718917303823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2468718917303823"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2017.12.011","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quels sont l\u2019objectif r\u00e9el et la port\u00e9e du d\u00e9pistage des aneuplo\u00efdies\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2017.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}